Drugs / Fuganlin Oral Liquid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02622659 | Mar 2012 → Mar 2014 | viral respiratory tract infection | Guangzhou Yipinhong Pharmaceutical CO.,LTD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fuganlin Oral Liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02622659 ↗ |
| Route | Oral | “Fuganlin Oral Liquid:oral” NCT02622659 ↗ |